Mersana Therapeutics Share Price Today
(NASDAQ: MRSN)

Name: Mersana Therapeutics Share Price Today (NASDAQ: MRSN) - Mersana Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Mersana Therapeutics share price is $0.43 & ₹36.42 as on 1 May 2025, 2.30 'hrs' IST

$0.43

▲

0.06

(17.19%)

Market is closed - opens 7 PM, 01 May 2025

View live Mersana Therapeutics share price in Dollar and Rupees. Guide to invest in Mersana Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mersana Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Mersana Therapeutics share price movements

Today's Low: $0.35
Today's High: $0.44
$0.43
18.26%
Downside
Day's Volatility :20.04%
Upside
2.18%
52 Weeks Low: $0.26
52 Weeks High: $3.63
$0.43
39.79%
Downside
52 Weeks Volatility :92.87%
Upside
88.15%

Mersana Therapeutics (MRSN) Returns

Period	Mersana Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-41.28%	-5.2%	0.0%
6 Months	-79.34%	-5.7%	0.0%
1 Year	-88.91%	-0.9%	0.0%
3 Years	-89.89%	6.9%	-5.1%

Mersana Therapeutics (MRSN) Key Statistics

in dollars & INR

Previous Close	$0.3694
Open	$0.3602
Today's High	$0.4396
Today's Low	$0.3515
Market Capitalization	$47.8M
Today's Volume	$2.3M
52 Week High	$3.63
52 Week Low	$0.2589
Revenue TTM	$40.5M
EBITDA	$-71.7M
Earnings Per Share (EPS)	$-0.56
Profit Margin	-170.86%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-505.14%

How to invest in Mersana Therapeutics Stock (MRSN) from India?

It is very easy for Indian residents to invest directly in Mersana Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mersana Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mersana Therapeutics or MRSN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mersana Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mersana Therapeutics shares which would translate to 1.969 fractional shares of Mersana Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mersana Therapeutics, in just a few clicks!

Returns in Mersana Therapeutics (MRSN) for Indian investors in Rupees

The Mersana Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Mersana Therapeutics investment value today

Current value as on today

₹14,227

Returns

₹85,773

(-85.77%)

Returns from Mersana Therapeutics Stock

₹87,240 (-87.24%)

Dollar Returns

₹1,467 (+1.47%)

Indian investors sentiment towards Mersana Therapeutics (MRSN)

-19%

Period: Mar 31, 2025 to Apr 30, 2025. Change in 30 Days versus previous period

Search interest for Mersana Therapeutics Stock from India on INDmoney has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Mersana Therapeutics

Nextech Invest AG
9.68%
EcoR1 Capital, LLC
9.09%
VR Adviser, LLC
8.23%
BlackRock Inc
7.39%
Bain Capital Life Sciences Investors, LLC
6.95%
Vanguard Group Inc
5.66%

Analyst Recommendation on Mersana Therapeutics

Rating

Trend

Buy

80%Buy

20%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Mersana Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Mersana Therapeutics Stock (MRSN)

What analysts predicted

Upside of 996.35%

Target:

$4.71

Current:

$0.43

Insights on Mersana Therapeutics Stock (Ticker Symbol: MRSN)

Price Movement
In the last 6 months, MRSN stock has moved down by -79.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 2.29M → 16.36M (in $), with an average increase of 52.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -11.50M → -14.11M (in $), with an average decrease of 22.8% per quarter
MRSN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.6% return, outperforming this stock by 160.5%
MRSN vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 92.8% return, outperforming this stock by 182.1%
Price to Sales
ForMRSN every $1 of sales, investors are willing to pay $1.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Mersana Therapeutics Technicals Summary

Sell

Neutral

Buy

Mersana Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Mersana Therapeutics (MRSN) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Mersana Therapeutics Inc	8.63%	-79.34%	-88.91%	-89.89%	-95.77%
Biontech Se	14.33%	-7.95%	15.74%	-28.71%	127.41%
Regeneron Pharmaceuticals, Inc.	-7.79%	-32.13%	-37.03%	-12.75%	5.0%
Vertex Pharmaceuticals Incorporated	3.75%	5.66%	25.06%	91.98%	90.0%
Alnylam Pharmaceuticals, Inc.	0.61%	-3.48%	71.59%	85.05%	88.33%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Mersana Therapeutics Inc	NA	NA	0.0	-0.79	-5.05	-0.25	NA	-0.08
Biontech Se	160.8	NA	0.04	-5.11	-0.03	-0.04	NA	80.89
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.96	39.38	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.35	17.95	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Mersana Therapeutics Inc	Buy	$47.8M	-95.77%	NA	-170.86%
Biontech Se	Buy	$29.5B	127.41%	160.8	-24.18%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	5.0%	15.94	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$127.6B	90.0%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	88.33%	NA	-12.37%

About Mersana Therapeutics

Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs. The company develops Emi-Le (XMT-1660), a B7-H4-targeting Dolasynthen ADC candidate, which is in Phase 1 clinical trial; and XMT-2056, an Immunosynthen ADC targeting a novel human epidermal growth factor receptor 2 that is in Phase 1 clinical trial. Its preclinical products portfolio includes XMT-2068 and XMT-2175. It has strategic research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana Biosciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

Organization	Mersana Therapeutics
Employees	102
CEO	Dr. Martin H. Huber M.D.
Industry	Health Technology

Management People of Mersana Therapeutics

Name	Title
Dr. Martin H. Huber M.D.	President, CEO & Director
Mr. Brian C. DeSchuytner	Senior VP, CFO & COO
Dr. Timothy B. Lowinger Ph.D.	Senior VP and Chief Science & Technology Officer
Ms. Alejandra Veronica Carvajal J.D.	Senior VP, Secretary & Chief Legal Officer
Mr. Mohan Bala Ph.D.	Senior VP & Chief Development Officer
Mr. Mikhail Papisov Ph.D.	Co-Founder
Mr. Ashish Mandelia	VP & Chief Accounting Officer
Mr. Jason Fredette	Senior Vice President of Investor Relations & Corporate Communications
Mr. Chuck Miller	Senior Vice President of Regulatory Affairs
Dr. Marc Damelin Ph.D.	Exe. Director and Head of Biology, Oncology, Antibody-Drug Conjugate ADC Discovery & Develop.

Important FAQs about investing in MRSN Stock from India :

What is Mersana Therapeutics share price today?

Mersana Therapeutics share price today stands at $0.43, Open: $0.36 ; Previous Close: $0.37 ; High: $0.44 ; Low: $0.35 ; 52 Week High: $3.63 ; 52 Week Low: $0.26.

The stock opens at $0.36, after a previous close of $0.37. The stock reached a daily high of $0.44 and a low of $0.35, with a 52-week high of $3.63 and a 52-week low of $0.26.

Can Indians buy Mersana Therapeutics shares?

Yes, Indians can invest in the Mersana Therapeutics (MRSN) from India.

With INDmoney, you can buy Mersana Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Mersana Therapeutics at zero transaction cost.

How can I buy Mersana Therapeutics shares from India?

It is very easy to buy Mersana Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mersana Therapeutics (MRSN) be purchased?

Yes, you can buy fractional shares of Mersana Therapeutics with INDmoney app.

What are the documents required to start investing in Mersana Therapeutics stocks?

To start investing in Mersana Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.